Type I interferon production of plasmacytoid dendritic cells under control

D Bencze, T Fekete, K Pázmándi - International journal of molecular …, 2021 - mdpi.com
One of the most powerful and multifaceted cytokines produced by immune cells are type I
interferons (IFNs), the basal secretion of which contributes to the maintenance of immune …

Flavonoids as potential phytotherapeutics to combat cytokine storm in SARS‐CoV‐2

A Gour, D Manhas, S Bag, B Gorain… - Phytotherapy …, 2021 - Wiley Online Library
Emergence of severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) infection,
COVID‐19, has become the global panic since December 2019, which urges the global …

[HTML][HTML] Differences and similarities between innate immune evasion strategies of human coronaviruses

H Hoenigsperger, R Sivarajan, KMJ Sparrer - Current Opinion in …, 2024 - Elsevier
Highlights•Human coronaviruses use distinctand similar strategies to counteract innate
defenses.•Insights from SARS-CoV-2 will inspire research on endemic and epidemic …

[HTML][HTML] Novel coronavirus disease (COVID-19) pandemic: A recent mini review

MF ur Rehman, C Fariha, A Anwar, N Shahzad… - Computational and …, 2021 - Elsevier
The COVID-19, caused by a novel coronavirus, was declared as a global pandemic by WHO
more than five months ago, and we are still experiencing a state of global emergency. More …

COVID-19 in children: expressions of type I/II/III interferons, TRIM28, SETDB1, and endogenous retroviruses in mild and severe cases

PA Tovo, S Garazzino, V Dapra, G Pruccoli… - International journal of …, 2021 - mdpi.com
Children with the new coronavirus disease 2019 (COVID-19) have milder symptoms and a
better prognosis than adult patients. Several investigations assessed type I, II, and III …

[HTML][HTML] Potential genes associated with COVID-19 and comorbidity

S Feng, F Song, W Guo, J Tan, X Zhang… - … journal of medical …, 2022 - ncbi.nlm.nih.gov
Hypertension, diabetes mellitus, and coronary artery disease are common comorbidities and
dangerous factors for infection and serious COVID-19. Polymorphisms in genes associated …

Corticosteroid therapy for COVID-19: A systematic review and meta-analysis of randomized controlled trials

YS Pulakurthi, JM Pederson, K Saravu, N Gupta… - Medicine, 2021 - journals.lww.com
Background: Corticosteroid treatment is an effective and common therapeutic strategy for
various inflammatory lung pathologies and may be an effective treatment for coronavirus …

[HTML][HTML] Transcriptomic similarities and differences in host response between SARS-CoV-2 and other viral infections

SA Thair, YD He, Y Hasin-Brumshtein, S Sakaram… - Iscience, 2021 - cell.com
The pandemic 2019 novel coronavirus disease (COVID-19) shares certain clinical
characteristics with other acute viral infections. We studied the whole-blood transcriptomic …

SARS-COV-2 as potential microRNA sponge in COVID-19 patients

C Li, R Wang, A Wu, T Yuan, K Song, Y Bai… - BMC Medical …, 2022 - Springer
Background MicroRNAs (miRNAs) are a class of small non-coding RNA that can
downregulate their targets by selectively binding to the 3′ untranslated region (3′ UTR) of …

Antimicrobial peptides and other peptide-like therapeutics as promising candidates to combat SARS-CoV-2

MS Mousavi Maleki, M Rostamian… - Expert review of anti …, 2021 - Taylor & Francis
Introduction: There are currently no specific drugs and universal vaccines for Coronavirus
disease 2019 (COVID-19), hence urgent effective measures are needed to discover and …